pillbase.ru

Adempas

Active substance: riociguat

riociguat

Centralised EU authorisationActive

Marketing holder: Bayer AG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 10
  • Adempas
    TABLET, FILM COATED · RIOCIGUAT .5 mg/1
    50419-250
    Bayer HealthCare Pharmaceuticals Inc.
  • Adempas
    TABLET, FILM COATED · RIOCIGUAT 2.5 mg/1
    50419-254
    Bayer HealthCare Pharmaceuticals Inc.
  • Adempas
    TABLET, FILM COATED · RIOCIGUAT 1 mg/1
    50419-251
    Bayer HealthCare Pharmaceuticals Inc.
  • Adempas
    TABLET, FILM COATED · RIOCIGUAT 1.5 mg/1
    50419-252
    Bayer HealthCare Pharmaceuticals Inc.
  • Adempas
    TABLET, FILM COATED · RIOCIGUAT 2 mg/1
    50419-253
    Bayer HealthCare Pharmaceuticals Inc.
All products in this country (10)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-6c44-7dcb-8286-c1b78f66734b,01a1208c-bb76-7179-9a6c-57f6a2816fe0,01a1208e-e150-72fc-9a54-646c55b1bdbd,01a12092-8518-7184-91a0-a04c15929efe,01a12093-9736-77ec-b5be-7493bc30a37c;count=10 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002737
Registration status
Active
ATC code
C02KX05
Sources
  • product · EMA · EMEA/H/C/002737 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002737 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002737 · Verified 2026-10-09